Subscribe to RSS
DOI: 10.1055/s-2006-949636
A Highly Efficient Approach for the Synthesis of Cationic Lipid DOSPA
Publication History
Publication Date:
24 August 2006 (online)
![](https://www.thieme-connect.de/media/synlett/200614/lookinside/thumbnails/10.1055-s-2006-949636-1.jpg)
Abstract
A highly efficient strategy has been developed for the synthesis of the cationic lipid, N-[2-({2,5-bis[(3-aminopropyl)amino]-1-oxopentyl}amino)ethyl]-N,N-dimethyl-2,3-bis[(1-oxo-9-octadecenyl)oxy] salt with hydrogen chloride (DOSPA). It involves the linkage of a cationic head group and a hydrophobic moiety in the presence of the standard coupling reagents.
Key words
cationic lipids - DNA - synthesis - liposome - transfection
- 1
Finkelstein R.Baughman RW.Steele FR. Mol. Ther. 2001, 3: 3 - 2
Kayser O.Kiderlen AF. Pharm. Biotechnol. 2004, 249 - 3
Ozawa K. Uirusu 2004, 54: 49 - 4
McGarrity GJ. Animal Cell Culture TechniquesClynes M. Springer; Berlin: 1998. p.600-612 - 5
Amalfitano A.Parks RJ. Curr. Gene Ther. 2002, 2: 111 - 6
Hauser H.Spitzer D.Verhoeyen E.Unsinger J.Wirth D. Cells Tissues Organs 2000, 167: 75 - 7
Suzuki M.Matsuse T.Isigatsubo Y. Curr. Mol. Med. 2001, 1: 67 - 8
Friedmann T. Sci. Am. 1997, 276: 96 - 9
Parker AL. J. Drug Targeting 2005, 13: 39 - 10
Miller AD. Medical and Biotechnology Applications, In Microspheres, Microcapsules & Liposomes Vol. 2: Citus Books; London: 1999. p.545 - 11
Bennett MJ.Aberle AM.Balasubramanian JG.Malone JG.Nantz MH.Malone RW. J. Liposome Res. 1996, 6: 545 - 12
Felgner PL.Tsai YJ.Felgner JH. Handbook of Nonmedical Applications of Liposomes Vol. 4: CRC Press; Boca Raton: 1996. p.43-56 - 13
Zabner J. Adv. Drug Deliv. Rev. 1997, 27: 17 - 14
Miller AD. Angew. Chem. Int. Ed. 1998, 37: 1769 - 15
Felgner PL.Gadek TR.Holm M.Roman R.Chan HW.Wenz M.Northrop JP.Ringold GM.Danielsen M. Proc. Natl. Acad. Sci. U.S.A. 1987, 84: 7413 - 16
Remy JS.Sirlin C.Vierling P.Behr JP. Bioconjugate Chem. 1994, 5: 647
References and Notes
Selected Data for Compound 4.
1H NMR (400 MHz, CDCl3): δ = 5.43 (m, 4 H CHCH), 4.11-3.89 (m, 7 H, OCH, OCH2), 3.59 (s, 6 H, 2 CH3), 3.51 (m, 6 H, NCH2CHO, NCH2), 2.00 (m, 8 H, CH2CHCH), 1.46-1.20 (m, 48 H, CH2), 0.93 (t, 6 H, J = 5.2 Hz, CH3). 13C NMR (100 MHz, CDCl3): δ = 130.9, 129.7 (CHCH), 74.6 (CHO), 72.1, 69.5, 68.2 (CH2O), 65.8, 62.4 (CH2NCH2), 53.9, 53.5 (CH3), 43.1 (CH2NCO), 32.8-22.8 (CH2CH2), 14.3 (CH3). MALDI-MS: m/z = 664.6765 [M + H+].
Selected Data for Compound 10.
1H NMR (400 MHz, CD3OD): δ = 5.38 (m, 4 H, CHCH), 3.92-3.02 (m, 30 H, CHCONH, NCH3, CH2O, CHO, CH2N), 2.06-1.20 (m, 70 H, CH2, CH3, CH2CH2NH2, CH2CH2NH, CH2CHCO). 13C NMR (100 MHz, CDCl3): δ = 155.2 (CO), 130.1, 129.9 (CHCH), 80.6, 79.8, 78.9, 78.5 [C(CH3)3], 72.9 (CHO), 72.8, 71.2 (CH2NCH2), 68.7, 68.0 (OCH2), 60.9 (NCHCONH), 53.9, 52.8 (NCH3), 52.1 (CONHCH2CH2), 47.8-38.2 (CH2NCO), 32.1-22.1 (CH2CH2, CH2CH2NHCO, CH2CHCO), 14.3 (CH3). MALDI-MS: m/z = 1072.1552 [M + H+].